Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TRILOGY ENERGY CORP. We currently have 22 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
TRILOGY ENERGY CORP
TRILOGY ENERGY CORP
Announces Second Quarter Financial and Operating Results
08 Aug 16
While the quarter modestly trailed our expectations, Trilogy’s spending represented only 11% of cash flow while reining in operating costs, and observing only modest production declines which should situate the Company well for 2H16e where more drilling activity is planned. With this release, we have made no material changes to our estimates, though note that operational catalysts will be ramping up in 2H16e. Sustained improvements to drilling costs may lead to a bump to our reinvestment efficiencies as more capital is deployed throughout the year. We are increasing our 12 month target price to $6.00 per share while electing to maintain our Market Perform ranking on the stock.
ANNOUNCES SECOND QUARTER FINANCIAL AND OPERATING RESULTS
05 Aug 16
Impact: Neutral. While the quarter trailed our expectations, Trilogy has managed to hold spending under cash flow while reining in operating costs, which should situate the Company well for 2H16e where more drilling activity is planned.
2Q16e Quarterly Preview
26 Jul 16
Some Recovery on Segmented Cash Flow Generation Over Q1 Though Still Down 56% Y/Y. In aggregate, the Intermediate, Mid, and Small Cap groups are expected to generate 2Q16e cash flow of $1,281 mm, $183 mm, and $53 mm, or $1.517 billion in total, that while depressed relative to the same period last year (~$2.647 billion combined), is up 17% sequentially from the prior quarter, largely on the strength of crude oil price recovery in the period. Severely weak natural gas pricing picture markedly reversed into summer, market likely to ignore financials for natural gas producers and look ahead to winter and formalization of sell-side 2018e estimates in coming months. Spot AECO natural gas prices recently crested C$2.60/mcf, and with a reasonable alignment of previously distressed NE BC Stn2 differentials, augmented by a withdrawal expected next week, view the market psyche as constructive and looking ahead, with the analogy that this market is shaping up to mirror 2012 still holding. That said, with crude oil poised to retest support levels, combined with strong stock price performance broadly observed YTD, we would characterize sentiment as slightly pessimistic in the near-term which could reduce or unwind momentum-based investment strategies that have worked thus far in 2016.
ANNOUNCES AMENDMENTS TO ITS CREDIT FACILITY; BORROWING BASE LOWERED, COVENANTS RELAXED
17 May 16
Impact: Neutral to slightly negative. The re-determination to $300 mm removes some margin of error for Trilogy and brings total borrowing capacity closer to our net debt estimate exiting 2Q16e, which is not ideal. That being said, our current estimates have Trilogy spending at or below cash flow for the remainder of the year on both FirstEnergy and current forward strip pricing, which should assist with deleveraging efforts moving into 2017e.
1Q16 Results Behind Expectations, Resource Preservation Theme of Capital Program
06 May 16
Given natural declines and voluntary shut-in of uneconomic production, Trilogy’s production was 2% shy of our expectations, alongside a slightly higher natural gas bias. Cash flow of $9.1 mm or $0.07 per share was behind FirstEnergy and consensus estimates of $0.10 per share. Capital spending of $22.3 mm outpaced cash flow as the Company addressed expiry issues in the Duvernay while taking advantage of notably improving well costs in its Montney oil and gas plays.
GMP FirstEnergy ― UK Energy morning research package
06 Dec 16
Transglobe Energy (TGL CN); BUY, C$5.25: Homeward bound… back to Canada | Great Eastern Energy Corporation (GEEC LN) (not covered): Reserves update in India | BP (BP LN) (not covered): Acquiring interest in Tangguh in Indonesia | Exillon Energy (EXI LN) (not covered): Production update in Russia | Genel Energy (GENL LN); SPECULATIVE BUY, £2.60: Receipt of payment for Taq Taq export in Kurdistan | ExxonMobil (XOM US) (not covered): Relinquishing blocks in Kurdistan
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
19 Jan 17
Aggregated Micro Power* (AMPH): Funding for first peaking power plant project (CORP) | The Mission Marketing Group* (TMMG): Positive trading update (CORP) | Cello (CLL): Increasingly backed by, and leveraging, technology (BUY) | 4imprint (FOUR): Growth backed by strong cash flow continues (BUY) | Allergy Therapeutics (AGY): Positive trading update and market share gains drive upgrades (BUY) | Shanta Gold (SHG): Q4 operating results (BUY) | Sound Energy (SOU): Tendrara extended well test result (BUY) | Revolution Bars (RBG): Price target increase (BUY)